Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: Who is at highest risk?

European Journal of Haematology

Volumn 81, Issue 3, 2008, Pages 242-243

  Caira, Morena ^a   Girmenia, Corrado ^b   Fadda, Rafaela Maria ^c   Mitra, Maria Enza ^c   Picardi, Marco ^d   Van Lint, Maria Teresa ^e   Nosari, Annamaria ^f   Candoni, Anna ^g   Bonini, Alessandro ^h   Mattei, Daniele ⁱ   De Waure, Chiara ^a   Fianchi, Luana ^a   Valentini, Caterina Giovanna ^a   Aversa, Franco ^j   Leone, Giuseppe ^a   Pagano, Livio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Palermo Hospital   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g UNIVERSITY OF UDINE   (Italy)

^h Reggio Emilia Hospital   (Italy)

ⁱ S CROCE E CARLE HOSPITAL   (Italy)

^j UNIVERSITY OF PERUGIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; CANCER CHEMOTHERAPY; CANDIDIASIS; COHORT ANALYSIS; CONIDIUM; FUNGAL COLONIZATION; FUNGAL VIRULENCE; FUNGUS SPORE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LETTER; MORTALITY; MOULD; MULTIPLE ORGAN FAILURE; MYCOSIS; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPSIS; STATISTICAL SIGNIFICANCE; STEROID THERAPY; YEAST;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, ACUTE; MYCOSES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 49349109514     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01096.x     Document Type: Letter

References (7)

1. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM 2004 study. Haematologica 2006 91: 1068 75.
2. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007 45: 1161 70.
3. Muhlemann K, Wenger C, Zenhausern R, Tauber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia 2005 19: 545 50.
4. Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000 181: 309 16.
5. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 34: 909 17.
6. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005 43 (Suppl 1 S49 58.
7. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34: 7 14.